Merck's promising experimental Covid-19 drug raises hopes for pill to fight virus

Posted on AllSides October 1st, 2021
From The Left
Seth Wenig, File/AP Photo

News that an experimental antiviral drug from Merck appears to halve the risk of hospitalization or death from Covid-19 has bolstered hopes of finding a simple at-home treatment for the virus.

The drug, molnupiravir, is given as a pill. It performed well enough in a late-stage clinical trial of adults at high risk of severe Covid-19 that the independent review board overseeing the study recommended that it be ended early. Now Merck and its partner Ridgeback Biotherapeutics will seek FDA authorization for the drug “as soon as possible,” they said...

Read full story

Politico

AllSides Media Bias Rating: Lean Left
AllSides Media Bias Rating: Lean Left
106713/84319
See full bias rating for Politico
Learn about media bias
https://www.politico.com/news/2021/10/01/merck-covid-drug-514888

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right